< Back to catalogue
Bempedoic acid + Ezetimibe
August 4, 2026Dapagliflozin + Metformin
August 4, 2026PHARMAZAC
Dapagliflozin
Dapagliflozin | SGLT-2 Inhibitor | Business Development
| F.C. TABS 5MG/TAB |
| F.C. TABS 10 MG/TAB |
| F.C. TABS 5MG/TAB |
| F.C. TABS 10 MG/TAB |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | Under Development |
| THERAPEUTIC AREA |
